Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
JNJ-87801493 by Johnson & Johnson for B-Cell Non-Hodgkin Lymphoma: Likelihood of Approval
JNJ-87801493 is under clinical development by Johnson & Johnson and currently in Phase I for B-Cell Non-Hodgkin Lymphoma. According to...